Probing cathepsin K activity with a selective substrate spanning its active site.

The limited availability of highly selective cathepsin substrates seriously impairs studies designed to monitor individual cathepsin activities in biological samples. Among mammalian cysteine proteases, cathepsin K has a unique preference for a proline residue at P2, the primary determinant of its substrate specificity. Interestingly, congopain from Trypanosoma congolense also accommodates a proline residue in its S2 subsite. Analysis of a congopain model showed that amino acids forming its S2 subsite are identical with those of cathepsin K, except Leu67 which is replaced by a tyrosine residue in cathepsin K. Furthermore, amino acid residues of the congopain S2' binding pocket, which accepts a proline residue, are strictly identical with those of cathepsin K. Abz-HPGGPQ-EDN2ph [where Abz represents o-aminobenzoic acid and EDN2ph (=EDDnp) represents N -(2,4-dinitrophenyl)-ethylenediamine], a substrate initially developed for trypanosomal enzymes, was efficiently cleaved at the Gly-Gly bond by cathepsin K (kcat/ K(m)=426000 M(-1) x s(-1)). On the other hand, Abz-HPGGPQ-EDN2ph was resistant to hydrolysis by cathepsins B, F, H, L, S and V (20 nM enzyme concentration) and the Y67L (Tyr67-->Leu)/L205A cathepsin K mutant (20 nM), but still acted as a competitive inhibitor. Taken together, the selectivity of Abz-HPGGPQ-EDN2ph to cathepsin K primarily depends on the S2 and S2' subsite specificities of cathepsin K and the ionization state of histidine at P3. Whereas Abz-HPGGPQ-EDN2ph was hydrolysed by wild-type mouse fibroblast lysates, its hydrolysis was completely abolished in the cathepsin K-deficient samples, indicating that Abz-HPGGPQ-EDN2ph can be used to monitor selectively cathepsin K activity in physiological fluids and cell lysates.

[1]  K. Abromeit.  Music Received , 2022, Notes.

[2]  R. Thomas,et al.  Cathepsin K mRNA and Protein Expression in Prostate Cancer Progression , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  D. Turk,et al.  Lysosomal cysteine proteases (cathepsins): promising drug targets. , 2003, Acta crystallographica. Section D, Biological crystallography.

[4]  D. Brömme,et al.  Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design. , 2002, Chemical reviews.

[5]  T. Welte,et al.  Expression of cathepsins B, H, K, L, and S during human fetal lung development , 2002, Developmental dynamics : an official publication of the American Association of Anatomists.

[6]  B. Gelb,et al.  Collagenase Activity of Cathepsin K Depends on Complex Formation with Chondroitin Sulfate* , 2002, The Journal of Biological Chemistry.

[7]  C. Craik,et al.  Selective inhibition of the collagenolytic activity of human cathepsin K by altering its S2 subsite specificity. , 2002, Biochemistry.

[8]  T. Welte,et al.  Cathepsin K – a marker of macrophage differentiation? , 2001, The Journal of pathology.

[9]  Y. Ru,et al.  Potent and Selective Inhibition of Human Cathepsin K Leads to Inhibition of Bone Resorption In Vivo in a Nonhuman Primate , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  T. Moreau,et al.  Subsite specificity of trypanosomal cathepsin L-like cysteine proteases. Probing the S2 pocket with phenylalanine-derived amino acids. , 2001, European journal of biochemistry.

[11]  E. Young,et al.  Pathologic gene expression in Gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin K. , 2000, Blood.

[12]  L. Juliano,et al.  Probing the specificity of cysteine proteinases at subsites remote from the active site: analysis of P4, P3, P2' and P3' variations in extended substrates. , 2000, The Biochemical journal.

[13]  D. Brömme,et al.  Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates. , 2000, Biochemistry.

[14]  J. Palmer,et al.  Localization of Rat Cathepsin K in Osteoclasts and Resorption Pits: Inhibition of Bone Resorption and Cathepsin K-Activity by Peptidyl Vinyl Sulfones , 1999, Biological chemistry.

[15]  E. Mehler,et al.  Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization. , 1999, Biochemistry.

[16]  P. Delmas,et al.  The Collagenolytic Activity of Cathepsin K Is Unique among Mammalian Proteinases* , 1998, The Journal of Biological Chemistry.

[17]  H. Chapman,et al.  Human Cathepsin F , 1998, The Journal of Biological Chemistry.

[18]  Sheila J. Jones,et al.  Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  V. Duance,et al.  Effects of transforming growth factor‐beta 1 on the assembly of matrix by bovine fibroblasts grown in a 3‐dimensional matrix , 1998 .

[20]  J G Gleason,et al.  Design of potent and selective human cathepsin K inhibitors that span the active site. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[21]  L. Juliano,et al.  A comparison of the enzymatic properties of the major cysteine proteinases from Trypanosoma congolense and Trypanosoma cruzi. , 1997, Molecular and biochemical parasitology.

[22]  D. Turk,et al.  Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. , 1997, Biological chemistry.

[23]  J. Scharfstein,et al.  Investigation of the substrate specificity of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, through the use of cystatin-derived substrates and inhibitors. , 1996, The Biochemical journal.

[24]  R. Ménard,et al.  The specificity of the S1' subsite of cysteine proteases , 1993, FEBS letters.

[25]  P. Webster,et al.  Identification of a 33-kilodalton immunodominant antigen of Trypanosoma congolense as a cysteine protease. , 1992, Molecular and biochemical parasitology.

[26]  T. Moreau,et al.  Photometric or fluorometric assay of cathepsin B, L and H and papain using substrates with an aminotrifluoromethylcoumarin leaving group. , 1991, Biochimica et biophysica acta.

[27]  C. Craik,et al.  Introduction of a cysteine protease active site into trypsin. , 1989, Biochemistry.

[28]  A. Lanzavecchia,et al.  Characterization of granzymes A and B isolated from granules of cloned human cytotoxic T lymphocytes. , 1988, Journal of immunology.

[29]  T. Moreau,et al.  Cysteine-proteinase-inhibiting function of T kininogen and of its proteolytic fragments. , 1988, European journal of biochemistry.

[30]  H. Kirschke,et al.  Enzyme-substrate interactions in the hydrolysis of peptides by cathepsins B and H from rat liver. , 1987, The Biochemical journal.

[31]  D. Yamashita,et al.  Cathepsin K and the design of inhibitors of cathepsin K. , 2000, Current pharmaceutical design.

[32]  J. Scharfstein,et al.  Discrimination of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, and mammalian cathepsins B and L, by a pH-inducible fluorogenic substrate of trypanosomal cysteine proteinases. , 1999, European journal of biochemistry.

[33]  A. Barrett,et al.  L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. , 1982, The Biochemical journal.